Hi-Clearance (1788) - Total Liabilities
Based on the latest financial reports, Hi-Clearance (1788) has total liabilities worth NT$2.03 Billion TWD (≈ $63.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Hi-Clearance's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Hi-Clearance - Total Liabilities Trend (2015–2024)
This chart illustrates how Hi-Clearance's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 1788 total assets.
Hi-Clearance Competitors by Total Liabilities
The table below lists competitors of Hi-Clearance ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Orzel Bialy S.A.
WAR:OBL
|
Poland | zł111.83 Million |
|
Eaton Vance New York MBF
NYSE MKT:ENX
|
USA | $86.56 Million |
|
Kumpulan Fima Bhd
KLSE:6491
|
Malaysia | RM598.21 Million |
|
GRM Overseas Limited
NSE:GRMOVER
|
India | Rs3.86 Billion |
|
Amway (Malaysia) Holdings Bhd
KLSE:6351
|
Malaysia | RM269.63 Million |
|
Thanulux Public Company Limited
BK:TNL
|
Thailand | ฿4.77 Billion |
|
Oncoclinicas do Brasil
SA:ONCO3
|
Brazil | R$7.02 Billion |
|
Tumosan Motor ve Traktor Sanayi AS
IS:TMSN
|
Turkey | TL12.82 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Hi-Clearance's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Hi-Clearance's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.69 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hi-Clearance's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hi-Clearance (2015–2024)
The table below shows the annual total liabilities of Hi-Clearance from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$1.96 Billion ≈ $61.70 Million |
+19.86% |
| 2023-12-31 | NT$1.63 Billion ≈ $51.48 Million |
-21.03% |
| 2022-12-31 | NT$2.07 Billion ≈ $65.19 Million |
-3.02% |
| 2021-12-31 | NT$2.13 Billion ≈ $67.22 Million |
-2.57% |
| 2020-12-31 | NT$2.19 Billion ≈ $68.99 Million |
+12.73% |
| 2019-12-31 | NT$1.94 Billion ≈ $61.20 Million |
+46.25% |
| 2018-12-31 | NT$1.33 Billion ≈ $41.85 Million |
+34.40% |
| 2017-12-31 | NT$988.28 Million ≈ $31.14 Million |
+8.25% |
| 2016-12-31 | NT$912.94 Million ≈ $28.76 Million |
+0.86% |
| 2015-12-31 | NT$905.20 Million ≈ $28.52 Million |
-- |
About Hi-Clearance
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more